3 Articles
3 Articles
Galderma Launches Sculptra in China
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss. Galderma announced the launch of Sculptra, a regenerative biostimulator with a unique poly-L-lactic acid formulation, in China. This follows Sculptra’s approval by China’s National Medical Products Administration for correcting mid-facial volume loss and/or contour deficiencies last year. The approval was ba…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage